A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol.
Saved in:
| Title: | A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. |
|---|---|
| Authors: | Kurokawa, Tomoya1,2 (AUTHOR), Iinuma, Tomohisa2 (AUTHOR), Ebisu, Haruna1 (AUTHOR), Yanagidaira, Tomoha1 (AUTHOR), Inaba, Yosuke1 (AUTHOR), Fujiwara, Tadami1 (AUTHOR), Hattori, Yoko1 (AUTHOR), Fukazawa, Tominaga3 (AUTHOR), Aoki, Takahiro3,4 (AUTHOR), Koseki, Haruhiko3 (AUTHOR), Hanaoka, Hideki1 (AUTHOR), Hanazawa, Toyoyuki2 (AUTHOR), Motohashi, Shinichiro4 (AUTHOR) motohashi@faculty.chiba-u.jp |
| Source: | PLoS ONE. 2/26/2026, Vol. 21 Issue 2, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0342387 |
